Johnson & Johnson (JNJ)
Operating profit margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Operating income | US$ in thousands | 30,427,000 | 29,474,000 | 17,754,000 | 14,490,000 | 14,238,000 |
Revenue | US$ in thousands | 84,021,000 | 79,428,000 | 93,356,000 | 82,174,000 | 81,474,000 |
Operating profit margin | 36.21% | 37.11% | 19.02% | 17.63% | 17.48% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $30,427,000K ÷ $84,021,000K
= 36.21%
The operating profit margin of Johnson & Johnson has shown stability over the past five years, ranging from 24.11% to 26.18%. In 2023, the operating profit margin was 25.84%, which indicates that the company generated $0.25 in operating profit for every dollar of sales. This consistent performance suggests that Johnson & Johnson has been effectively managing its operating expenses relative to its revenue, maintaining a healthy level of profitability.
Peer comparison
Dec 31, 2023
Company name
Symbol
Operating profit margin
Johnson & Johnson
JNJ
36.21%
Abbott Laboratories
ABT
16.43%
AbbVie Inc
ABBV
23.49%
Alkermes Plc
ALKS
25.25%
Amphastar P
AMPH
30.57%
ANI Pharmaceuticals Inc
ANIP
10.34%
Arcus Biosciences Inc
RCUS
-290.60%
Biomarin Pharmaceutical Inc
BMRN
6.66%
Bristol-Myers Squibb Company
BMY
-20.64%
Catalent Inc
CTLT
-17.10%
Catalyst Pharmaceuticals Inc
CPRX
21.80%